Neil Skolnik, MD, Jefferson Health, reviews the new management guidelines for COPD from the 2023 GOLD report. According to Dr Skolnik, you shouldn’t hesitate to use dual bronchodilator therapy in patients with significant symptoms, and don’t hesitate to escalate to triple therapy if patients have a significant exacerbation burden.